Report overview

The report describes CEPI's 2025 progress against its CEPI 2.0 strategy and the 100 Days Mission, including advances in vaccine candidates, outbreak response and vaccine technology. It highlights expanded laboratory, preclinical and manufacturing networks and reports US$ 354.7 million in 2025 programme disbursements.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language
Pages
File size

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women in management

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services

Report overview

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language
Pages
File size

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women in management

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services

Annual Progress Report

Report overview

Document

Standards & Assurance

ESG & Materiality

ESG data

Build your research dataset.

Annual Progress Report

Report overview

Document

Standards & Assurance

ESG & Materiality

ESG data

Build your research dataset.